Mon, Dec 22, 2014, 8:12 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

ONYX Pharmaceuticals, Inc. Message Board

  • felledbyanaxe felledbyanaxe Apr 17, 1998 2:08 PM Flag

    ASCO abstracts

    The ASCO abstract book is out, and I've seen 4 Onyx 0-15 abstracts so far (still looking). If an Onyx employee reads this message, maybe you could help us out with the abstract numbers for others.
    Of the 4 I've read, 1 was of particular importance to shareholders (#1509), the phase 2 trial of intratumoral therapy in adnaced head and neck CA. The results were quite encouraging. Of 13 evaluables, 2 CRs, 2PRs, and 5 SDs (6-12 wks) were seen. Therapy was well-tolerated and symptom improvement was noted in 3 pts.

    I wish the pancreatic CA and liver mets phase 1 data had been a little better, but overall, I think shareeholders should be quite encouraged by these early findings. I am.

124.700.0000(0.00%)Sep 30 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Gilead Sciences Inc.
NASDAQMon, Dec 22, 2014 4:00 PM EST
Henry Schein, Inc.
NASDAQMon, Dec 22, 2014 4:00 PM EST
Sirona Dental Systems Inc.
NASDAQMon, Dec 22, 2014 3:59 PM EST